Home LiteratureArticle Details
PMID: 12376529 Published · ppublish English Journal Article

Synergistic activity of the ninth and tenth FIII domains of human fibronectin depends upon structural stability.

The Journal of biological chemistry ·Vol. 278 ·No. 1 ·2003-01-03 ·Pages 491-7

Altroff H, Choulier L, Mardon HJ

Abstract

The ninth and tenth FIII domains (FIII9-10) of human fibronectin act in synergy to promote cell adhesion via the interaction with integrin receptors. Here we describe the functional and structural properties of a set of recombinant FIII9-10 mutants containing various alanine substitutions within the key synergistic site, DRVPHSRN in FIII9, either alone or in combination with another substitution (Leu(1408) to Pro), on the opposite face of FIII9, that increases stability and the functional capacity of FIII9-10. We show that the introduction of mutations into the synergistic sequence of FIII9-10 has a negative effect on the adhesion of baby hamster kidney fibroblasts and results in reduced ability of these ligands to recognize integrin alpha(5)beta(1). Conformational stability of the FIII9 domain in the synergy site mutants is likewise reduced in comparison with native FIII9. The Leu(1408) to Pro substitution in mutant FIII9-10 proteins carrying substitutions in the synergy site results in a substantial recovery of the adhesive activity of the mutants and affinity to alpha(5)beta(1). In keeping with the enhancement of functional activity, the Leu(1408) to Pro substitution in the FIII9-10 synergy site mutants also causes a significant increase in conformational stability of FIII9. These observations imply a strong positive correlation between the biological activity and conformational stability of the assessed FIII9-10 mutants and suggest that a Leu(1408) to Pro substitution restores the biological activity of the mutants via their ability to restore their conformational stability. We conclude that domain stability may be a major determinant of the synergistic potential of FIII9. Our data underscore the value of using more than one approach in such structure-function studies and the requirement for validating the global structural integrity of protein ligands in which sequences that disrupt function have been perturbed.

MeSH Terms
Animals Cell Adhesion/physiology Cell Line Cricetinae Fibroblasts/physiology Fibronectins/chemistry,genetics,metabolism Humans Integrin alpha5beta1/metabolism Ligands Models, Molecular Mutation Protein Binding Protein Conformation Protein Denaturation Recombinant Proteins/genetics,metabolism Statistics as Topic Surface Plasmon Resonance Thermodynamics
Chemicals
Fibronectins Integrin alpha5beta1 Ligands Recombinant Proteins
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Altroff Harri
Nuffield Department of Obstetrics and Gynaecology, University of Oxford, Women's Centre, John Radcliffe Hospital, Headington, Oxford OX3 9DU, United Kingdom.
Choulier Laurence
Mardon Helen J
References (23)
23 references, click to expand
  1. 2.0 A crystal structure of a four-domain segment of human fibronectin encompassing the RGD loop and synergy region.
    Cell. 1996 Jan 12;84(1):155-64 PMID: 8548820
  2. Structural requirements for biological activity of the ninth and tenth FIII domains of human fibronectin.
    J Biol Chem. 1997 Mar 7;272(10):6159-66 PMID: 9045628
  3. Module-module interactions in the cell binding region of fibronectin: stability, flexibility and specificity.
    J Mol Biol. 1997 Feb 7;265(5):565-79 PMID: 9048949
  4. Defining the topology of integrin alpha5beta1-fibronectin interactions using inhibitory anti-alpha5 and anti-beta1 monoclonal antibodies. Evidence that the synergy sequence of fibronectin is recognized by the amino-terminal repeats of the alpha5 subunit.
    J Biol Chem. 1997 Jul 11;272(28):17283-92 PMID: 9211865
  5. A comparison of the folding kinetics and thermodynamics of two homologous fibronectin type III modules.
    J Mol Biol. 1997 Aug 1;270(5):763-70 PMID: 9245603
  6. Solution structure and dynamics of linked cell attachment modules of mouse fibronectin containing the RGD and synergy regions: comparison with the human fibronectin crystal structure.
    J Mol Biol. 1998 Apr 3;277(3):663-82 PMID: 9533887
  7. Cooperative activity of alpha4beta1 and alpha4beta7 integrins in mediating human B-cell lymphoma adhesion and chemotaxis on fibronectin through recognition of multiple synergizing binding sites within the central cell-binding domain.
    Blood. 1999 Feb 15;93(4):1221-30 PMID: 9949164
  8. Differential activation of focal adhesion kinase, Rho and Rac by the ninth and tenth FIII domains of fibronectin.
    J Cell Sci. 1999 Sep;112 (Pt 17):2937-46 PMID: 10444388
  9. The Protein Data Bank.
    Nucleic Acids Res. 2000 Jan 1;28(1):235-42 PMID: 10592235
  10. Comparison of the early stages of forced unfolding for fibronectin type III modules.
    Proc Natl Acad Sci U S A. 2001 May 8;98(10):5590-5 PMID: 11331785
  11. Crystal structure of the extracellular segment of integrin alpha Vbeta3 in complex with an Arg-Gly-Asp ligand.
    Science. 2002 Apr 5;296(5565):151-5 PMID: 11884718
  12. The eighth FIII domain of human fibronectin promotes integrin alpha5beta1 binding via stabilization of the ninth FIII domain.
    J Biol Chem. 2001 Oct 19;276(42):38885-92 PMID: 11500513
  13. Defining fibronectin's cell adhesion synergy site by site-directed mutagenesis.
    J Cell Biol. 2000 Apr 17;149(2):521-7 PMID: 10769040
  14. Novel mutant human fibronectin FIII9-10 domain pair with increased conformational stability and biological activity.
    Protein Eng. 2002 Dec;15(12):1021-4 PMID: 12601142
  15. Fibronectin-integrin interactions.
    Front Biosci. 1997 Mar 1;2:d126-46 PMID: 9159220
  16. Fibronectin/integrin interaction induces tyrosine phosphorylation of a 120-kDa protein.
    Cell Regul. 1991 Nov;2(11):951-64 PMID: 1725602
  17. Requirement for the synergy site for cell adhesion to fibronectin depends on the activation state of integrin alpha 5 beta 1.
    J Biol Chem. 1995 Sep 15;270(37):21612-8 PMID: 7545166
  18. Function and receptor specificity of a minimal 20 kilodalton cell adhesive fragment of fibronectin.
    Cell Adhes Commun. 1995 Feb;3(1):13-25 PMID: 7538414
  19. The short amino acid sequence Pro-His-Ser-Arg-Asn in human fibronectin enhances cell-adhesive function.
    J Biol Chem. 1994 Oct 7;269(40):24756-61 PMID: 7929152
  20. Identification of a novel integrin binding site in fibronectin. Differential utilization by beta 3 integrins.
    J Biol Chem. 1994 Apr 8;269(14):10856-63 PMID: 7511609
  21. The three-dimensional structure of the tenth type III module of fibronectin: an insight into RGD-mediated interactions.
    Cell. 1992 Nov 13;71(4):671-8 PMID: 1423622
  22. Tyrosine phosphorylation of paxillin and pp125FAK accompanies cell adhesion to extracellular matrix: a role in cytoskeletal assembly.
    J Cell Biol. 1992 Nov;119(4):893-903 PMID: 1385444
  23. The role of the ninth and tenth type III domains of human fibronectin in cell adhesion.
    FEBS Lett. 1994 Mar 7;340(3):197-201 PMID: 8131845
Article Info
Journal
The Journal of biological chemistry
Abbr.
J Biol Chem
ISSN
0021-9258
Published
2003-01-03
Epub
2002-00-09
Pages
491-7
Language
English
Region
United States
NLM ID
2985121R
PMCID
PMC1626583
Subset
IM
Grants
Wellcome Trust · United Kingdom
Wellcome Trust · 073028 · United Kingdom
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com